Larvol Delta - ASLAN-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Provides-Corporate-Update

eblasakimab (ASLAN004) - ASLAN Pharma

https://www.globenewswire.com/news-release/2022/03/25/2410128/0/en/ASLAN-Pharmaceuticals-Reports-Fourth-Quarter-and-Full-Year-2021-Financial-Results-and-Provides-Corporate-Update.html

Mar 25, 2022

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next